DGX

Quest Diagnostics
Health Care Services · Health Care · as of 2026-11-20
Last close
$261.25
+0.8% on the session
1-year return
+42.9%
+34.9% over six months
Volatility
24.0%
annualized, trailing year
Max drawdown
-11.6%
worst peak to trough, 1y
What the numbers say

Quest Diagnostics is a health care services name in the health care sector. Over the past year it returned +42.9%, against +7.5% over three months and +7.4% over one. It trades 20.8% above its 200-day average, so the longer trend is confirming recent strength. Annualized volatility of 24.0% is moderate by single-stock standards.

Its worst peak-to-trough decline over the year was -11.6%, and it has traded a median $233M a day, the figure that decides whether a position can actually be entered and exited at posted prices. Its daily moves correlate -0.04 with the S&P 500 proxy, so it has been moving substantially on its own.

Where it ranks
Within Health Care#13 of 59
Stronger than 79% of its sector on the momentum profile
Across the whole index#29 of 497

How DGX scores on all four profiles

Its standing on steadiness, defensiveness and rebound, plus the factor-by-factor breakdown behind each score, and its closest and least-correlated peers among 4 others in Health Care Services.

Start a free 7-day trial
Full metrics
1 day+0.8%
1 week+0.6%
1 month+7.4%
3 months+7.5%
6 months+34.9%
1 year+42.9%
12-1 momentum+33.0%
Volatility (1y, annualized)24.0%
Max drawdown (1y)-11.6%
Distance vs 200-day average+20.8%
Return per unit of risk1.78
Median daily dollar volume$233M
Free newsletter

Get DGX when it shows up in a ranking

Two editions a weekday, free, ranked lists built from this same data, on whatever the market is talking about.

Everything on this page is computed from daily adjusted closing prices. It contains no earnings, balance-sheet, guidance or ownership data, and it is not a valuation. Nothing here is tailored to your circumstances or a recommendation to buy or sell. Past performance does not predict future results.